Workflow
联盛化学(301212) - 2024 Q4 - 年度业绩预告
RealsunChemRealsunChem(SZ:301212)2025-01-20 08:35

Financial Performance - The estimated net profit attributable to shareholders for 2024 is projected to be between 20 million and 25 million RMB, representing a decrease of 71.88% compared to the same period last year, which was 71.11 million RMB[3]. - The estimated net profit after deducting non-recurring gains and losses is expected to be between 17 million and 22 million RMB, down 74.63% from 67.01 million RMB in the previous year[3]. - The decline in performance is primarily due to significant decreases in sales prices of major products, despite a gradual recovery in overall sales volume, leading to reduced gross margins[5]. Interest Income - The company has seen a reduction in interest income compared to the previous year due to decreased idle funds from fundraising projects being used for cash management[5]. Financial Reporting - The financial data in this earnings forecast has not been audited by the annual audit firm[6]. - The specific financial data for the 2024 fiscal year will be disclosed in the company's annual report[7].